IDCRC Investigator Profile: Evan Anderson, MD
Evan Anderson, MD is a professor of pediatrics and medicine at Emory University School of Medicine and attending physician at Children’s Healthcare of Atlanta. Dr. Anderson's initial research focused on rotavirus infections of adults and is now focused on respiratory infections in adults (e.g., RSV, influenza, COVID) and vaccines and vaccine clinical trials. He serves on the IDCRC respiratory infections Expert Working Group.
Briefly describe the IDCRC-supported trials you’ve worked on
I worked on DMID 20-0003 (Phase I Moderna), DMID 21-0002 (late boost of 20-0003 participants and naïve individuals receiving viral variant vaccine), DMID 21-0012 (Mix N Match), DMID 20-0006 (ACTT study – supporting Nadine Rouphael, Aneesh Mehta, MD and the VTEU’s Hope Clinic in recruiting and enrolling hospitalized adults for ACTT). We have conducted the Phase III Moderna (COVE) and Phase III Janssen studies (ENSEMBLE), and now are enrolling actively into the Moderna pediatric study of vaccine in children <12 years of age (KidCOVE). Learn more about IDCRC Studies
I’ve worked on vaccine and therapeutic studies from A to Z over the years in the VTEU: anthrax, avian influenza vaccines (e.g., H3N2v, H7N9, H5N8), chikungunya, Ebola, hepatitis E, influenza, MVA (IMVAMUNE), norovirus, osteomyelitis, the ‘omics of response to vaccination, rotavirus, RSV, Staphylococcus aureus, tularemia, and Zika. It has been quite an experience!
How long have you worked with a VTEU?
I was recruited by Paul Spearman, MD to join the Emory Vaccine & Treatment Evaluation Unit (VTEU) in 2012 from Northwestern University. I was recruited to step into the shoes of one of the original Emory VTEU PIs, Harry Keyserling, MD, who was retiring after conducting clinical trials for 30 years. He had conducted at least one study on all the routine vaccines in the childhood vaccination schedule. During my years of training and while at Northwestern as a junior faculty member, I had dreamed of getting to work in a VTEU. I now have the privilege to serve as a multiple PI of the Emory VTEU along with my colleagues Carlos del Rio, MD and Nadine Rouphael, MD.Briefly describe the IDCRC-supported trials you’ve worked on
I worked on DMID 20-0003 (Phase I Moderna), DMID 21-0002 (late boost of 20-0003 participants and naïve individuals receiving viral variant vaccine), DMID 21-0012 (Mix N Match), DMID 20-0006 (ACTT study – supporting Nadine Rouphael, Aneesh Mehta, MD and the VTEU’s Hope Clinic in recruiting and enrolling hospitalized adults for ACTT). We have conducted the Phase III Moderna (COVE) and Phase III Janssen studies (ENSEMBLE), and now are enrolling actively into the Moderna pediatric study of vaccine in children <12 years of age (KidCOVE). Learn more about IDCRC StudiesI’ve worked on vaccine and therapeutic studies from A to Z over the years in the VTEU: anthrax, avian influenza vaccines (e.g., H3N2v, H7N9, H5N8), chikungunya, Ebola, hepatitis E, influenza, MVA (IMVAMUNE), norovirus, osteomyelitis, the ‘omics of response to vaccination, rotavirus, RSV, Staphylococcus aureus, tularemia, and Zika. It has been quite an experience!